IPG-1094 | Interleukin Related interleukin-related.com

Product Name :
IPG-1094

Search keywords :
MIF

drugId :
null

Target Vo:
Macrophage migration inhibitory factor

Target Vo Short Name :
MIF

Moa_Name:
Macrophage migration inhibitory factor inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Nanjing Immunophage Biotech Co Ltd

Active Company_Name :
Nanjing Immunophage Biotech Co Ltd

Active Indication_Name:
Lupus Nephritis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Tislelizumab Epigenetic Reader Domain
Phospho-c-Jun(S63) Rabbit mAb References
PCK1 Antibody: PCK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to PCK1. It can be used for ICC,IHC-P,WB assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts